Filing Details

Accession Number:
0001179110-20-010368
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-10-09 16:04:27
Reporting Period:
2020-10-07
Accepted Time:
2020-10-09 16:04:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597264 Blueprint Medicines Corp BPMC () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1532475 Alan Mark Goldberg C/O Blueprint Medicines Corporation
45 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-10-07 5,454 $19.53 9,016 No 4 M Direct
Common Stock Disposition 2020-10-07 5,454 $100.00 3,562 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2020-10-07 5,454 $0.00 5,454 $19.53
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
5,455 2026-06-23 No 4 M Direct
Footnotes
  1. Effected pursuant to a trading plan adopted on August 5, 2020 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This option was granted on June 23, 2016 and is fully vested as of the date hereof.